Nomura initiates coverage on this newly listed CRDMO stock and sees an 18% upside despite a 22% correction

Global brokerage firm Nomura has initiated coverage on the newly listed Anthem Biosciences with a ‘Buy’ rating and a target price of Rs 740 for December 2026, implying an upside of 18% from current levels.The initiation comes despite the stock falling 22.4% over the past three months since listing in July 2025. Nomura believes the […]

Sudeep Pharma IPO: Mukul Agrawal, Prashant Jain among investors in Rs 268 crore anchor book

Sudeep Pharma, a technology-focused maker of excipients and specialty ingredients used in pharmaceuticals, food and nutrition, has raised Rs 268 crore from a heavyweight roster of anchor investors, setting the tone for its Rs 895 crore IPO set to open on November 21.The company allotted 45.27 lakh shares of Rs 593 each to anchors, drawing […]